Innate Pharma seeks to follow best practice in corporate governance.

The company set up a Compensation Committee in 2001 and an Audit Committee in 2003.

In May 2025, Innate Pharma was transformed into a SA with a Board of Directors.

The Board of Directors is responsible for defining the Company's strategy. Its members have significant experience in the biopharmaceutical sector.


Governance Committees

To date, the committees are:

  • the compensation and nomination committee,
  • the audit and Sustainability committee,
  • the transaction committee,
  • the R&D committee.

All four committees report to the Board of Directors.

Governance Documents

Download item year list
Download Description
Whistleblower Policy (opens in new window)
Market Ethics Charter (opens in new window)
Code of Ethics (opens in new window)

According to the General Regulations of the Autorité des Marchés Financiers (AMF) (Article 223-22), declarations of Directors’ Shareholdings are directly available on the AMF's website (under Decisions & disclosures).